Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Pig pathogen added to disease model portfolio
Researchers complete validation of bacterial pathogen.

Researchers at Moredun Scientific have completed the validation of a Streptococcus suis Serotype 2 disease model in weaner piglets. It is hoped that it will prove useful in the formulation of vaccines and studies into therapeutic efficacy.

Streptococcus suis, a bacterial pathogen of pigs, is of great importance to the global pig industry because of the economic ramifications of disease outbreaks and the according effects on the welfare of infected herds. The disease can make the jump to humans if protocols to prevent the spread of blood-borne diseases are not followed.

An outbreak which started in the Sichaun Province of western China in July 2005 led to over two hundred people being infected and 38 fatalities. The disease has also been identified as the most common cause of meningitis in Vietnam.

Serotype 2 is the strain of the disease which has been identified as being responsible for the majority of infections, and no licensed vaccine is currently available.

Head of Animal Health at Moredun Scientific David Reddick said: "We are pleased to extend our disease model portfolio to offer a highly effective model of S.suis infection to our animal health clients supporting their efforts to prevent and control the disease." 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.